PMV Pharmaceuticals GAAP EPS of -$0.37 misses by $0.02 [Seeking Alpha]
PMV Pharmaceuticals, Inc. (PMVP)
Company Research
Source: Seeking Alpha
Cash, cash equivalents, and marketable securities of $197.9 million as of September 30, 2024, providing expected cash runway to end of 2026. More on PMV Pharmaceuticals Seeking Alpha's Quant Rating on PMV Pharmaceuticals Historical earnings data for PMV Pharmaceuticals Financial information for PMV Pharmaceuticals Recommended For You More Trending News
Show less
Read more
Impact Snapshot
Event Time:
PMVP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PMVP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PMVP alerts
High impacting PMV Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
PMVP
News
- Sionna Therapeutics Announces Appointment of Laurie Stelzer to its Board of Directors [Yahoo! Finance]Yahoo! Finance
- PMV Pharmaceuticals Reports Third Quarter 2024 Financial ResultsGlobeNewswire
- PMV Pharmaceuticals Provides a Progress Update on PYNNACLE Clinical TrialGlobeNewswire
- PMV Pharmaceuticals (NASDAQ:PMVP) Is In A Good Position To Deliver On Growth Plans [Yahoo! Finance]Yahoo! Finance
PMVP
Earnings
- 5/9/24 - Beat
PMVP
Sec Filings
- 11/20/24 - Form S-3
- 11/14/24 - Form SC
- 11/7/24 - Form 10-Q
- PMVP's page on the SEC website